New chemo strategy aims to boost pancreatic cancer survival
NCT ID NCT02959879
Summary
This study tested whether giving chemotherapy before surgery (neoadjuvant chemo) works better than the standard approach of surgery followed by chemo for pancreatic cancer that can be surgically removed. It compared two different chemotherapy combinations (FOLFOX and FOLFIRINOX) given before surgery to the standard treatment. The goal was to see if this approach helps more patients survive longer and reduces the chance of the cancer coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE PANCREATIC DUCT ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rouen University Hospital
Rouen, France
Conditions
Explore the condition pages connected to this study.